Townson Sharon

Chief Scientific Officer at GLUE

Sold, on record
$424k
Dollars the filings state
Form 4 sales
5
Latest Jul 6, 2026
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • GLUEMonte Rosa Therapeutics, Inc.Chief Scientific Officer

Sales by reason

4
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale GLUENo plan
    Jan 5, 2026 2026

    Sold 3,155 shares at $15.17 ($48k)

    Townson Sharon, Chief Scientific Officer

    No 10b5-1 planSold 4.4% of holdings ($1.1M position)67,845 shares leftFirst sale on recordFiling

  2. 2 Form 144 notice GLUENotice
    May 29, 2026 +144 days

    Filed to sell 24,000 shares ($465k)

    Townson Sharon, Officer

    10b5-1 planFiling

  3. 3 Form 4 sale GLUERoutine
    May 29, 2026 same day

    Sold 6,000 shares at $19.87 ($119k)

    Townson Sharon, Chief Scientific Officer

    10b5-1 planSold 8.1% of holdings ($1.5M position)67,845 shares leftFollows a Form 144Filing

  4. 4 Form 4 sale GLUERoutine
    Jun 17, 2026 +19 days

    Sold 3,000 shares at $19.00 ($57k)

    Townson Sharon, Chief Scientific Officer

    10b5-1 planSold 4.2% of holdings ($1.3M position)67,845 shares leftFollows a Form 144Filing

  5. 5 Form 4 sale GLUERoutine
    Jun 23, 2026 +6 days

    Sold 3,000 shares at $20.00 ($60k)

    Townson Sharon, Chief Scientific Officer

    10b5-1 planSold 4.2% of holdings ($1.4M position)67,845 shares left1x usual sizeFollows a Form 144Filing

  6. 6 Form 4 sale GLUERoutine
    Jul 6, 2026 +13 days

    Sold 6,000 shares at $23.31 ($140k)

    Townson Sharon, Chief Scientific Officer

    10b5-1 planSold 8.1% of holdings ($1.7M position)67,845 shares left1.9x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (6)

Form 144 notices and Form 4 sales by Townson Sharon
Source
Jul 6, 2026Jul 7, 2026GLUEChief Scientific OfficerForm 4 sale6,000$140k8.1%RoutineSEC
Jun 23, 2026Jun 25, 2026GLUEChief Scientific OfficerForm 4 sale3,000$60k4.2%RoutineSEC
Jun 17, 2026Jun 18, 2026GLUEChief Scientific OfficerForm 4 sale3,000$57k4.2%RoutineSEC
May 29, 2026Jun 1, 2026GLUEChief Scientific OfficerForm 4 sale6,000$119k8.1%RoutineSEC
May 29, 2026May 29, 2026GLUEOfficerForm 144 notice24,000$465kNoticeSEC
Jan 5, 2026Jan 5, 2026GLUEChief Scientific OfficerForm 4 sale3,155$48k4.4%No planSEC